Literature DB >> 8086109

Foot infections in diabetes: evaluation and management.

A W Karchmer1, G W Gibbons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086109

Source DB:  PubMed          Journal:  Curr Clin Top Infect Dis        ISSN: 0195-3842


× No keyword cloud information.
  7 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Letter: microbiological and clinical mismanagement of non healing diabetic leg ulcers?

Authors:  Adenike Ao Ogunshe
Journal:  Int Wound J       Date:  2011-08-09       Impact factor: 3.315

Review 3.  Optimal treatment of infected diabetic foot ulcers.

Authors:  Edward B Jude; Philip F Unsworth
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Osteomyelitis: approach to diagnosis and treatment.

Authors:  Joseph M Fritz; Jay R McDonald
Journal:  Phys Sportsmed       Date:  2008-12       Impact factor: 2.241

5.  Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement.

Authors:  F J Aragón-Sánchez; J J Cabrera-Galván; Y Quintana-Marrero; M J Hernández-Herrero; J L Lázaro-Martínez; E García-Morales; J V Beneit-Montesinos; D G Armstrong
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

6.  Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review.

Authors:  Lisa Matricciani; Kerwin Talbot; Sara Jones
Journal:  J Foot Ankle Res       Date:  2011-12-04       Impact factor: 2.303

7.  Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1).

Authors:  Leonie Nijenhuis-Rosien; Nanne Kleefstra; Maurice J Wolfhagen; Klaas H Groenier; Henk J G Bilo; Gijs W D Landman
Journal:  Trials       Date:  2015-03-22       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.